Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-10-17 Director's Dealing
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Arctic Bioscience - Mandatory notification of trade' and explicitly details a share purchase by the CSO, Hogne Hallaråker. It cites regulatory requirements pursuant to Regulation EU 596/2014 (MAR) article 19, which governs insider transactions and major shareholding notifications. Since this document reports personal share transactions by a director/executive (CSO), it directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions an 'attached notification,' the core content is the insider trade disclosure itself, making DIRS the most specific fit over a general RPA or RNS.
2024-10-17 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 100% confidence The document text is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a specific transaction ('Share Purchase') involving common shares by an individual identified as a Medical Director (a person discharging managerial responsibilities). This structure perfectly matches the definition of a Director's Dealing report, which tracks personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2024-10-16 English
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a specific transaction ('Share Purchase') involving common shares by an individual identified as a Medical Director (a person discharging managerial responsibilities). This structure perfectly matches the definition of a Director's Dealing report, which tracks personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2024-10-16 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 99% confidence The document text is titled "Arctic Bioscience - Meldepliktig handel" (Mandatory Trading) and details a transaction where a Medical Director, Runhild Gammelsæter, purchased 10,000 shares. It explicitly mentions that this information is subject to MAR (Market Abuse Regulation) Article 19 and the Norwegian Securities Trading Act § 5-12. This content directly relates to personal share transactions by company directors and executives (insider trades). This aligns perfectly with the definition for Director's Dealing (DIRS). The document is short and contains the details of the trade, not just an announcement of a report.
2024-10-16 Norwegian
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Arctic Bioscience - Mandatory notification of trade' and explicitly details a transaction (purchase of 10,000 shares) by a Medical Director (Runhild Gammelsæter). This type of filing reports personal share transactions by company directors and executives, which directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions an 'attached notification,' the core content is the director's trade itself, making DIRS the most specific classification over a general RPA or RNS.
2024-10-16 English
Arctic Bioscience - Meldepliktig handel
Director's Dealing Classification · 100% confidence The document is structured as a formal notification template detailing a transaction involving a person discharging managerial responsibilities (Hogne Hallaråker, CSO) and shares of the issuer (Arctic Bioscience AS). Specifically, it reports a 'Share Purchase' of 'Common shares in ABS' on a specific date (16/10-2024). This perfectly matches the definition of Director's Dealing (insider trades by executives/directors). Classification Code: DIRS.
2024-10-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.